Integration of cytokine and heterologous receptor signaling pathways

Nature Immunology

Volumn 10, Issue 4, 2009, Pages 333-339

  Bezbradica, Jelena S ^a   Medzhitov, Ruslan ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL RECEPTOR; CYTOKINE; CYTOKINE RECEPTOR; IMMUNOGLOBULIN; IMMUNOMODULATING AGENT; INTERLEUKIN 10; JANUS KINASE; STAT PROTEIN;

ANTIGEN PRESENTATION; CARBOXY TERMINAL SEQUENCE; CD8+ T LYMPHOCYTE; CELL COMMUNICATION; CELL FATE; CELL STIMULATION; CELL TRANSFORMATION; CHROMATIN ASSEMBLY AND DISASSEMBLY; CYTOKINE PRODUCTION; DENDRITIC CELL; DRUG EFFECT; DRUG EFFICACY; DRUG RESEARCH; DRUG SYNTHESIS; DRUG TREATMENT FAILURE; ENZYME ACTIVATION; GENE EXPRESSION; HUMAN; IMMUNE RESPONSE; IMMUNOMODULATION; IMMUNOPATHOLOGY; IMMUNOREGULATION; INNATE IMMUNITY; NONHUMAN; PHAGOCYTOSIS; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; PROTEIN DEGRADATION; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FAMILY; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN MOTIF; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; REVIEW; RHEUMATOID ARTHRITIS; SIGNAL TRANSDUCTION; T LYMPHOCYTE ACTIVATION; TARGET CELL DESTRUCTION; TRANSCRIPTION REGULATION; UBIQUITINATION;

ANIMALS; CELL COMMUNICATION; CYTOKINES; HUMANS; JANUS KINASES; MODELS, BIOLOGICAL; RECEPTOR CROSS-TALK; RECEPTORS, CYTOKINE; SIGNAL TRANSDUCTION; STAT TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC;

EID: 62849116942     PISSN: 15292908     EISSN: 15292916     Source Type: Journal    
DOI: 10.1038/ni.1713     Document Type: Review

References (109)

1. Murray, P.J. The JAK-STAT signaling pathway: Input and output integration. J. Immunol. 178, 2623-2629 (2007).
2. Nathan, C. & Sporn, M. Cytokines in context. J. Cell Biol. 113 981-986 (1991).
3. Haan, C., Kreis, S., Margue, C. & Behrmann, I. Jaks and cytokine receptors - an intimate relationship. Biochem. Pharmacol. 72 1538-1546 (2006).
4. Firmbach-Kraft, I., Byers, M., Shows, T., Dalla-Favera, R. & Krolewski, J.J. tyk2, prototype of a novel class of non-receptor tyrosine kinase genes. Oncogene 5, 1329-1336 (1990).
5. Ihle, J.N. The Janus protein tyrosine kinase family and its role in cytokine signaling. Adv. Immunol. 60, 1-35 (1995).
6. Harpur, A.G., Andres, A.C., Ziemiecki, A., Aston, R.R. & Wilks, A.F. JAK2, a third member of the JAK family of protein tyrosine kinases. Oncogene 7, 1347-1353 (1992).
7. Wilks, A.F. Cloning members of protein-tyrosine kinase family using polymerase chain reaction. Methods Enzymol. 200, 533-546 (1991).
8. Kishimoto, T., Taga, T. & Akira, S. Cytokine signal transduction. Cell 76, 253-262 (1994).
9. Gadina, M. et al. Signaling by type I and II cytokine receptors: ten years after. Curr. Opin. Immunol. 13, 363-373 (2001).
10. Leonard, W.J. & O'Shea, J.J. Jaks and STATs: Biological implications. Annu. Rev. Immunol. 16, 293-322 (1998).
11. O'Shea, J.J., Gadina, M. & Schreiber, R.D. Cytokine signaling in 2002: new surprises in the Jak/Stat pathway. Cell 109 (suppl.), S121-S131 (2002).
12. Ihle, J.N., Witthuhn, B.A., Quelle, F.W., Yamamoto, K. & Silvennoinen, O. Signaling through the hematopoietic cytokine receptors. Annu. Rev. Immunol. 13, 369-398 (1995).
13. Takeda, K. & Akira, S. STAT family of transcription factors in cytokine-mediated biological responses. Cytokine Growth Factor Rev. 11, 199-207 (2000).
14. Gil, M.P. et al. Biologic consequences of Stat1-independent IFN signaling. Proc. Natl. Acad. Sci. USA 98, 6680-6685 (2001).
15. Ramana, C.V., Gil, M.P., Schreiber, R.D. & Stark, G.R. Stat1-dependent and -independent pathways in IFN-γ-dependent signaling. Trends Immunol. 23, 96-101 (2002).
16. Qing, Y. & Stark, G.R. Alternative activation of STAT1 and STAT3 in response to interferon-γ. J. Biol. Chem. 279, 41679-41685 (2004).
17. Costa-Pereira, A.P. et al. Mutational switch of an IL-6 response to an interferon-γ-like response. Proc. Natl. Acad. Sci. USA 99, 8043-8047 (2002).
18. Horng, T., Bezbradica, J.S. & Medzhitov, R. NKG2D signaling is coupled to the interleukin 15 receptor signaling pathway. Nat. Immunol. 8, 1345-1352 (2007).
19. Tassiulas, I. et al. Amplification of IFN-α-induced STAT1 activation and inflammatory function by Syk and ITAM-containing adaptors. Nat. Immunol. 5, 1181-1189 (2004).
20. Schroder, K., Sweet, M.J. & Hume, D.A. Signal integration between IFNγ and TLR signalling pathways in macrophages. Immunobiology 211 511-524 (2006).
21. Bosisio, D. et al. Stimulation of toll-like receptor 4 expression in human mononuclear phagocytes by interferon-γ: A molecular basis for priming and synergism with bacterial lipopolysaccharide. Blood 99, 3427-3431 (2002).
22. Guyre, P.M., Morganelli, P.M. & Miller, R. Recombinant immune interferon increases immunoglobulin G Fc receptors on cultured human mononuclear phagocytes. J. Clin. Invest. 72, 393-397 (1983).
23. Nimmerjahn, F., Bruhns, P., Horiuchi, K. & Ravetch, J.V. FcγRIV : A novel FcR with distinct IgG subclass specificity. Immunity 23 41-51 (2005).
24. Okayama, Y., Kirshenbaum, A.S. & Metcalfe, D.D. Expression of a functional highaffinity IgG receptor, FcγRI, on human mast cells: up-regulation by IFN-γ. J. Immunol. 164, 4332-4339 (2000).
25. Pricop, L. et al. Differential modulation of stimulatory and inhibitory Fcγ receptors on human monocytes by Th1 and Th2 cytokines. J. Immunol. 166, 531-537 (2001).
26. Meresse, B. et al. Coordinated induction by IL15 of a TCR-independent NKG2D signaling pathway converts CTL into lymphokine-activated killer cells in celiac disease. Immunity 21, 357-366 (2004).
27. Lucas, M., Schachterle, W., Oberle, K., Aichele, P. & Diefenbach, A. Dendritic cells prime natural killer cells by trans-presenting interleukin 15. Immunity 26, 503-517 (2007).
28. Imada, K. et al. Stat5b is essential for natural killer cell-mediated proliferation and cytolytic activity. J. Exp. Med. 188, 2067-2074 (1998).
29. Minagawa, M. et al. Enforced expression of Bcl-2 restores the number of NK cells, but does not rescue the impaired development of NKT cells or intraepithelial lymphocytes, in IL-2/IL-15 receptor β-chain-deficient mice. J. Immunol. 169, 4153-4160 (2002).
30. Malek, T.R. The biology of interleukin-2. Annu. Rev. Immunol. 26, 453-479 (2008).
31. Liao, W. et al. Priming for T helper type 2 differentiation by interleukin 2-mediated induction of interleukin 4 receptor α-chain expression. Nat. Immunol. 9, 1288-1296 (2008).
32. + T cells. Nat. Immunol. 3, 549-557 (2002).
33. Szabo, S.J., Dighe, A.S., Gubler, U. & Murphy, K.M. Regulation of the interleukin (IL)-12R β2 subunit expression in developing T helper 1 (Th1) and Th2 cells. J. Exp. Med. 185, 817-824 (1997).
34. Veldhoen, M., Hocking, R.J., Atkins, C.J., Locksley, R.M. & Stockinger, B. TGFß in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells. Immunity 24 179-189 (2006).
35. + T helper cells. Cell 126, 1121-1133 (2006).
36. McGeachy, M.J. & Cua, D.J. Th17 cell differentiation: The long and winding road. Immunity 28, 445-453 (2008).
37. Schindler, U., Wu, P., Rothe, M., Brasseur, M. & McKnight, S.L. Components of a Stat recognition code: Evidence for two layers of molecular selectivity. Immunity 2, 689-697 (1995).
38. Horvath, C.M., Wen, Z. & Darnell, J.E. Jr. A STAT protein domain that determines DNA sequence recognition suggests a novel DNA-binding domain. Genes Dev. 9, 984-994 (1995).
39. Schroder, K., Hertzog, P.J., Ravasi, T. & Hume, D.A. Interferon-γ: An overview of signals, mechanisms and functions. J. Leukoc. Biol. 75, 163-189 (2004).
40. Zhang, X., Wrzeszczynska, M.H., Horvath, C.M. & Darnell, J.E. Jr. Interacting regions in Stat3 and c-Jun that participate in cooperative transcriptional activation. Mol. Cell. Biol. 19, 7138-7146 (1999).
41. Shi, M., Lin, T.H., Appell, K.C. & Berg, L.J. Janus-kinase-3-dependent signals induce chromatin remodeling at the Ifng locus during T helper 1 cell differentiation. Immunity 28, 763-773 (2008).
42. Zhu, J., Cote-Sierra, J., Guo, L. & Paul, W.E. Stat5 activation plays a critical role in Th2 differentiation. Immunity 19, 739-748 (2003).
43. Kim, S.T., Fields, P.E. & Flavell, R.A. Demethylation of a specific hypersensitive site in the Th2 locus control region. Proc. Natl. Acad. Sci. USA 104, 17052-17057 (2007).
44. + T cellmediated suppression by dendritic cells. Science 299, 1033-1036 (2003).
45. Hu, X. et al. IFN-γ suppresses IL-10 production and synergizes with TLR2 by regulating GSK3 and CREB/AP-1 proteins. Immunity 24, 563-574 (2006).
46. Alexander, W.S. & Hilton, D.J. The role of suppressors of cytokine signaling (SOCS) proteins in regulation of the immune response. Annu. Rev. Immunol. 22, 503-529 (2004).
47. Yoshimura, A., Naka, T. & Kubo, M. SOCS proteins, cytokine signalling and immune regulation. Nat. Rev. Immunol. 7, 454-465 (2007).
48. Nakagawa, R. et al. SOCS-1 participates in negative regulation of LPS responses. Immunity 17, 677-687 (2002).
49. Mansell, A. et al. Suppressor of cytokine signaling 1 negatively regulates Toll-like receptor signaling by mediating Mal degradation. Nat. Immunol. 7, 148-155 (2006).
50. Ryo, A. et al. Regulation of NF-κB signaling by Pin1-dependent prolyl isomerization and ubiquitin-mediated proteolysis of p65/RelA. Mol. Cell 12, 1413-1426 (2003).
51. Rothlin, C.V., Ghosh, S., Zuniga, E.I., Oldstone, M.B. & Lemke, G. TAM receptors are pleiotropic inhibitors of the innate immune response. Cell 131, 1124-1136 (2007).
52. Nelms, K., Keegan, A.D., Zamorano, J., Ryan, J.J. & Paul, W.E. The IL-4 receptor: Signaling mechanisms and biologic functions. Annu. Rev. Immunol. 17, 701-738 (1999).
53. Keegan, A.D. et al. An IL-4 receptor region containing an insulin receptor motif is important for IL-4-mediated IRS-1 phosphorylation and cell growth. Cell 76, 811-820 (1994).
54. Sun, X.J. et al. Role of IRS-2 in insulin and cytokine signalling. Nature 377, 173-177 (1995).
55. Aronica, M.A., Goenka, S. & Boothby, M. IL-4-dependent induction of BCL-2 and BCL-X(L)IN activated T lymphocytes through a STAT6- and pi 3-kinase-independent pathway. Cytokine 12, 578-587 (2000).
56. Gadina, M. et al. The docking molecule gab2 is induced by lymphocyte activation and is involved in signaling by interleukin-2 and interleukin-15 but not other common γ chain-using cytokines. J. Biol. Chem. 275, 26959-26966 (2000).
57. Gadina, M., Stancato, L.M., Bacon, C.M., Larner, A.C. & O'Shea, J.J. Involvement of SHP-2 in multiple aspects of IL-2 signaling: Evidence for a positive regulatory role. J. Immunol. 160, 4657-4661 (1998).
58. + Tregs. J. Clin. Invest. 116, 2521-2531 (2006).
59. + regulatory T cells. J. Immunol. 172, 5287-5296 (2004).
60. Johnston, J.A. et al. Tyrosine phosphorylation and activation of STAT5, STAT3, and Janus kinases by interleukins 2 and 15. Proc. Natl. Acad. Sci. USA 92, 8705-8709 (1995).
61. Budagian, V., Bulanova, E., Paus, R. & Bulfone-Paus, S. IL-15/IL-15 receptor biology: A guided tour through an expanding universe. Cytokine Growth Factor Rev. 17, 259-280 (2006).
62. Bulanova, E. et al. The IL-15Rα chain signals through association with Syk in human B cells. J. Immunol. 167, 6292-6302 (2001).
63. McDonald, P.P., Russo, M.P., Ferrini, S. & Cassatella, M.A. Interleukin-15 (IL-15) induces NF-κB activation and IL-8 production in human neutrophils. Blood 92, 4828-4835 (1998).
64. Ratthe, C. & Girard, D. Interleukin-15 enhances human neutrophil phagocytosis by a Syk-dependent mechanism: Importance of the IL-15Rα chain. J. Leukoc. Biol. 76, 162-168 (2004).
65. Gu, H. et al. New role for Shc in activation of the phosphatidylinositol 3-kinase/Akt pathway. Mol. Cell. Biol. 20 7109-7120 (2000).
66. Bulanova, E. et al. Mast cells express novel functional IL-15 receptor α isoforms. J. Immunol. 170, 5045-5055 (2003).
67. Budagian, V. et al. A promiscuous liaison between IL-15 receptor and Axl receptor tyrosine kinase in cell death control. EMBO J. 24, 4260-4270 (2005).
68. Tangye, S.G., Phillips, J.H. & Lanier, L.L. The CD2-subset of the Ig superfamily of cell surface molecules: Receptor-ligand pairs expressed by NK cells and other immune cells. Semin. Immunol. 12, 149-157 (2000).
69. Maldonado, R.A., Irvine, D.J., Schreiber, R. & Glimcher, L.H. A role for the immunological synapse in lineage commitment of CD4 lymphocytes. Nature 431, 527-532 (2004).
70. Chang, J.T. et al. Asymmetric T lymphocyte division in the initiation of adaptive immune responses. Science 315, 1687-1691 (2007).
71. Kondadasula, S.V. et al. Colocalization of the IL-12 receptor and FcγRIa to natural killer cell lipid rafts leads to activation of ERK and enhanced production of interferon-γ. Blood 111, 4173-4183 (2008).
72. Takaoka, A. et al. Cross talk between interferon-γ and -α/ß signaling components in caveolar membrane domains. Science 288 2357-2360 (2000).
73. Mitani, Y. et al. Cross talk of the interferon-α/ß signalling complex with gp130 for effective interleukin-6 signalling. Genes Cells 6, 631-640 (2001).
74. Hu, X. et al. Sensitization of IFN-γ Jak-STAT signaling during macrophage activation. Nat. Immunol. 3, 859-866 (2002).
75. Mizukoshi, E. et al. Upregulation of type I interferon receptor by IFN-gamma. J. Interferon Cytokine Res. 19, 1019-1023 (1999).
76. Wang, L. et al. 'Tuning' of type I interferon-induced Jak-STAT1 signaling by calciumdependent kinases in macrophages. Nat. Immunol. 9, 186-193 (2008).
77. Kovarik, P., Stoiber, D., Novy, M. & Decker, T. Stat1 combines signals derived from IFN-γ and LPS receptors during macrophage activation. EMBO J. 17, 3660-3668 (1998).
78. Kovarik, P. et al. Specificity of signaling by STAT1 depends on SH2 and C-terminal domains that regulate Ser727 phosphorylation, differentially affecting specific target gene expression. EMBO J. 20, 91-100 (2001).
79. Visconti, R. et al. Importance of the MKK6/p38 pathway for interleukin-12-induced STAT4 serine phosphorylation and transcriptional activity. Blood 96, 1844-1852 (2000).
80. Nair, J.S. et al. Requirement of Ca2+ and CaMKII for Stat1 Ser-727 phosphorylation in response to IFN-γ. Proc. Natl. Acad. Sci. USA 99, 5971-5976 (2002).
81. Decker, T. & Kovarik, P. Serine phosphorylation of STATs. Oncogene 19, 2628-2637 (2000).
82. Kovarik, P. et al. Stress-induced phosphorylation of STAT1 at Ser727 requires p38 mitogen-activated protein kinase whereas IFN-γ uses a different signaling pathway. Proc. Natl. Acad. Sci. USA 96 13956-13961 (1999).
83. Boekhoudt, G.H., Frazier-Jessen, M.R. & Feldman, G.M. Immune complexes suppress IFN-γ signaling by activation of the FcγRI pathway. J. Leukoc. Biol. 81, 1086-1092 (2007).
84. Feldman, G.M., Chuang, E.J. & Finbloom, D.S. IgG immune complexes inhibit IFNgamma- induced transcription of the Fc gamma RI gene in human monocytes by preventing the tyrosine phosphorylation of the p91 (Stat1) transcription factor. J. Immunol. 154, 318-325 (1995).
85. Du, Z. et al. Inhibition of IFN-α signaling by a PKC- and protein tyrosine phosphatase SHP-2-dependent pathway. Proc. Natl. Acad. Sci. USA 102, 10267-10272 (2005).
86. Bode, J.G. et al. LPS and TNFα induce SOCS3 mRNA and inhibit IL-6-induced activation of STAT3 in macrophages. FEBS Lett. 463 365-370 (1999).
87. Bode, J.G. et al. TNF-α induces tyrosine phosphorylation and recruitment of the Src homology protein-tyrosine phosphatase 2 to the gp130 signal-transducing subunit of the IL-6 receptor complex. J. Immunol. 171, 257-266 (2003).
88. Kiu, H. et al. Mechanism of crosstalk inhibition of IL-6 signaling in response to LPS and TNFα. Growth Factors 25, 319-328 (2007).
89. Zhu, J. et al. Transient inhibition of interleukin 4 signaling by T cell receptor ligation. J. Exp. Med. 192, 1125-1134 (2000).
90. Ivashkiv, L.B. A signal-switch hypothesis for cross-regulation of cytokine and TLR signalling pathways. Nat. Rev. Immunol. 8, 816-822 (2008).
91. Brilot, F., Strowig, T., Roberts, S.M., Arrey, F. & Munz, C. NK cell survival mediated through the regulatory synapse with human DCs requires IL-15Rα. J. Clin. Invest. 117, 3316-3329 (2007).
92. V amosi, G. et al. IL-2 and IL-15 receptor α-subunits are coexpressed in a supramolecular receptor cluster in lipid rafts of T cells. Proc. Natl. Acad. Sci. USA 101, 11082-11087 (2004).
93. Call, M.E., Pyrdol, J., Wiedmann, M. & Wucherpfennig, K.W. The organizing principle in the formation of the T cell receptor-CD3 complex. Cell 111, 967-979 (2002).
94. Feng, J., Call, M.E. & Wucherpfennig, K.W. The assembly of diverse immune receptors is focused on a polar membrane-embedded interaction site. PLoS Biol. 4, e142 (2006).
95. Dylke, J., Lopes, J., Dang-Lawson, M., Machtaler, S. & Matsuuchi, L. Role of the extracellular and transmembrane domain of Ig-α/ß in assembly of the B cell antigen receptor (BCR). Immunol. Lett. 112, 47-57 (2007).
96. Stevens, T.L., Blum, J.H., Foy, S.P., Matsuuchi, L. & DeFranco, A.L. A mutation of the mu transmembrane that disrupts endoplasmic reticulum retention. Effects on association with accessory proteins and signal transduction. J. Immunol. 152, 4397-4406 (1994).
97. Moore, D.T., Berger, B.W. & DeGrado, W.F. Protein-protein interactions in the membrane: Sequence, structural, and biological motifs. Structure 16, 991-1001 (2008).
98. Daniels, M.A., Hogquist, K.A. & Jameson, S.C. Sweet 'n' sour: The impact of differential glycosylation on T cell responses. Nat. Immunol. 3, 903-910 (2002).
99. Rudd, P.M. et al. Roles for glycosylation of cell surface receptors involved in cellular immune recognition. J. Mol. Biol. 293, 351-366 (1999).
100. Stanley, P. & Cummings, R.D. Structures common to different glycans. in Essentials of Glycobiology 2nd edn. (eds. Varki, A.C. et al. ch. 13 (Cold Spring Harbor Laboratory Press, Woodbury, New York, USA, 2009).
101. + T lymphocytes induce polarized exocytosis of secretory lysosomes by dendritic cells with release of interleukin-1β and cathepsin D. Blood 98, 2152-2159 (2001).
102. Semino, C., Angelini, G., Poggi, A. & Rubartelli, A. NK/iDC interaction results in IL-18 secretion by DCs at the synaptic cleft followed by NK cell activation and release of the DC maturation factor HMGB1. Blood 106, 609-616 (2005).
103. Borg, C. et al. NK cell activation by dendritic cells (DCs) requires the formation of a synapse leading to IL-12 polarization in DCs. Blood 104, 3267-3275 (2004).
104. Huse, M., Lillemeier, B.F., Kuhns, M.S., Chen, D.S. & Davis, M.M. T cells use two directionally distinct pathways for cytokine secretion. Nat. Immunol. 7, 247-255 (2006).
105. Kupfer, A., Mosmann, T.R. & Kupfer, H. Polarized expression of cytokines in cell conjugates of helper T cells and splenic B cells. Proc. Natl. Acad. Sci. USA 88, 775-779 (1991).
106. Murray, R.Z., Kay, J.G., Sangermani, D.G. & Stow, J.L. A role for the phagosome in cytokine secretion. Science 310, 1492-1495 (2005).
107. Holst, J. et al. Scalable signaling mediated by T cell antigen receptor-CD3 ITAMs ensures effective negative selection and prevents autoimmunity. Nat. Immunol. 9, 658-666 (2008).
108. Meylan, E. et al. RIP1 is an essential mediator of Toll-like receptor 3-induced NF-κB activation. Nat. Immunol. 5, 503-507 (2004).
109. Antoniv, T.T. & Ivashkiv, L.B. Dysregulation of interleukin-10-dependent gene expression in rheumatoid arthritis synovial macrophages. Arthritis Rheum. 54, 2711-2721 (2006)